In the BD rat model, treatment with a selective neutrophil elastase inhibitor, sivelestat sodium, decreased the expression of IL-1β, significantly improved the islet yield and function in vitro, and suppressed hypercytokinemia-mediated beta-cell death (82). The gene discussed is IL1B; the disease is Behcet disease.